Expression and immune infiltration studies of IL‐33‐ST2‐NF‐κB signaling pathway in prostate cancer
The Prostate · 2024
DOI: 10.1002/pros.24778 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Prostate, 2024. Verfasst von Han Wang und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Medical College, Beihua University, Jilin, China. Hauptthemen laut MEDLINE: Interleukin-33, Prostatic Neoplasms, Interleukin-1 Receptor-Like 1 Protein, NF-kappa B. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: Department of Science and Technology of Jilin Province, Graduate Innovation Project of Beihua University.
Abstract (Originalsprache)
Background
To analyze the expression of interleukin‐33 (IL‐33), growth‐stimulated expression gene 2 (ST2), nuclear factor‐kappaB (NF‐κB) and immune cell infiltration in prostate cancer, this study aims to provide an experimental basis for the clinical prevention and treatment of prostate cancer.
Methods
The expression of IL‐33 in PCa tissues was analyzed using TCGA, TIMER and HPA databases. Using the UALCAN database, the systematic exploration of the relationship between IL‐33 and various clinicopathological parameters was conducted. The correlation between IL‐33 expression and immune cell infiltration was investigated using TIMER, CIBERSORT and GEPIA databases. To verify these analyses, 22 cases of normal prostate (NP), 76 cases of benign prostatic hyperplasia (BPH), and 100 cases of PCa were recruited. Immunohistochemical staining was performed to examine the expression of IL‐33, ST2, NF‐κB, and the infiltration of immune cells. Correlations between these factors were then determined.
Results
The expression of IL‐33, ST2 and NF‐κB was significantly lower in PCa tissues compared with NP ( p < 0.05). IL‐33 was not associated with age in PCa but showed associations with race, molecular characteristics, lymph node metastatic status, TP53 mutation and tumor grade. Furthermore, IL‐33 was associated with immune cell infiltration. Positive correlations were observed between IL‐33 and ST2 expressions, as well as between IL‐33 and CD68 + macrophages in BPH and PCa.
Conclusions
IL‐33, ST2 and NF‐κB are lowly expressed in PCa tissues, their expression decreases with the increasing malignancy of cancer. IL‐33, ST2 and NF‐κB are factors associated with PCa immune infiltration. IL‐33 has an inhibitory effect on prostate cancer through the IL‐33/ST2/NF‐κB signalling pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Basic Medical College, Beihua University, Jilin, China.
- Department of Rehabilitation, School of Nursing, Jilin University, Changchun, China.
- People's hospital in Yushu city, Yushu, China.
- Academy of Chinese Medical Sciences, Henan University of Chinese Medicine, Zhengzhou, China.
ORCID-Profile: Han Wang, Lijing Zhao
Förderung
- Department of Science and Technology of Jilin Province
- Graduate Innovation Project of Beihua University
Zitieren
APA
Wang, H., He, K., Liu, Y., Yang, L., Wang, Z., Wang, H., Bai, C., Liu, J., Zhao, L., Ma, D., & Liu, Y. (2024). Expression and immune infiltration studies of IL‐33‐ST2‐NF‐κB signaling pathway in prostate cancer. The Prostate. https://doi.org/10.1002/pros.24778
Vancouver
Wang H, He K, Liu Y, Yang L, Wang Z, Wang H, et al. Expression and immune infiltration studies of IL‐33‐ST2‐NF‐κB signaling pathway in prostate cancer. The Prostate. 2024. doi:10.1002/pros.24778
BibTeX
@article{Wang2024,
author = {Wang, Han and He, Kang and Liu, Yuqi and Yang, Lijuan and Wang, Zhenjiang and Wang, Helin and Bai, Chengxia and Liu, Jian and Zhao, Lijing and Ma, Dongrui and Liu, Yanbo},
title = {Expression and immune infiltration studies of IL‐33‐ST2‐NF‐κB signaling pathway in prostate cancer},
journal = {The Prostate},
year = {2024},
doi = {10.1002/pros.24778}
}
EUVIMED